Abingworth

Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies. Since 1973, Abingworth has invested in over 175 life science companies, leading to 46 M&As and 70+ IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.

Vala Capital 🌱

Vala is a European VC backing the best founders. We support start up and high growth companies led by teams that have the potential to change the world. We invest our capital, but also our experience and our time - our collaborative approach helps young companies excel. Sustainability sits at the heart of our decision-making, and all portfolio companies must agree to clear sustainability objectives in order to work with us. In fact, we make our capital conditional on it. Above all, we love building lifelong relationships with the founder we back, which are based on trust, respect and a shared vision.

Connect Ventures

Connect is the Product VC. We are a thesis-led, pan-European pre-seed and seed stage VC. We invest in opinionated products, crafted with love, and loved by many. We've been backing product-led founders since 2012. Our investments include Truelayer, Typeform, Oyster, Lifebit, Kheiron, Faks and Sprinque. Our specialisms cut across SaaS, fintech, consumer, digital health and Web3. Collectively, we're passionate about the power of product to transform people's lives. We started Connect to back companies that help create the world we want to live in, and it's hard to change the world without scale. That's why we're in the business of investing in outlier companies — those with the potential to create impact on a massive scale.

Andurance Ventures LLP

Andurance Ventures is a Limited Liability Partnership authorised and regulated by the Financial Conduct Authority to advise investors in technology ventures with a strong focus on digital knowledge and content management start-ups in the consumer and enterprise space.

Columna Capital

We invest in European lower mid-market companies with ambitious growth strategies. Founded in 2009, Columna Capital is an entrepreneurial investment firm with offices in London, Lugano (Switzerland) and Luxembourg. Led by four partners, the Columna team consists of an engaged group of professionals that actively support ambitious management teams and entrepreneurs to drive organic growth and execute on consolidation opportunities. Typically, we invest in profitable companies with revenue of €15-100 million. We are a long term partner and our success is based on our ability to identify unique opportunities with growth potential where we aim to at least double the size of the business over the investment period.